Gapping down
In reaction to disappointing earnings/guidance: AM -3.3%, ( sees 2015 adjusted EBITDA of $150 -160 mln and DCF $135-145 mln ), WHX -3.3%, IBM -2.4%, NSLP -1.5%, (also announces that the Partnership and its general partner have been named as defendants in a petition filed in state court on January 13, 2015, by its former Chairman and Senior Geologist, David J. Chernicky and entities he controls), CA -1.3%, AMD -1.3%, AMD -1.3%, FITB -1.3%, IBKR -1.2%, STNG -0.5%, .
Other news: ZFGN -7.1% (announces proposed public offering of of 2,840,909 shares of common stock), ARNA -6.6% (intends to offer and sell shares of its common stock), XON -4.3% ( announces proposed public offering of $150 million of its common stock ), MBLY -3.7% (has filed a registration statement for a secondary public offering by selling shareholders; size not disclosed),FANG -3.4% (launches $1.5 mln in common stock offering), KERX -3.3% (commenced a $100 mln underwritten public offering of shares of its common stock), PBYI -3.2% (announced it is commencing a public offering of 1 mln shares of its common stock; terms not disclosed), QCOM -3.1% (has been dropped from next Samsung (SSNLF) smartphone, according to reports), SYRG -3% (provided operations update and updated fiscal second quarter production guidance; co's second fiscal quarter production is running below expectations due to a delay in completions by other operators), ZINC -1.7% (announces it plans to offer 5 mln shares of its common stock), OWW -1.2% (following yesterday's intraday move higher on reports of potential sale)
Analyst comments: EGO -11.2% (downgraded to Neutral from Outperform at Credit Suisse), AN -3.5% (downgraded to Neutral from Buy at Goldman), WYNN -1.8% (downgraded to Neutral from Buy at Nomura), FMS -1.5% (downgraded to Neutral from Buy at UBS, downgraded to Equal Weight at Barclays), LVS -1.4% (downgraded to Neutral from Buy at Nomura), HEES -1.4% (downgraded to Neutral from Buy at UBS ), SRPT -1.1% (downgraded to Neutral from Outperform at Credit Suisse ), CL -0.9% (downgraded to Neutral from Buy at UBS), WMT -0.9% (downgraded to Equal-Weight from Overweight at Morgan Stanley), BRKS -0.8% (assumed with a Underperform at Credit Suisse), CHD -0.7% (downgraded to Neutral from Buy at UBS), VZ -0.5% (downgraded to Equal Weight from Overweight at Barclays)
In reaction to disappointing earnings/guidance: AM -3.3%, ( sees 2015 adjusted EBITDA of $150 -160 mln and DCF $135-145 mln ), WHX -3.3%, IBM -2.4%, NSLP -1.5%, (also announces that the Partnership and its general partner have been named as defendants in a petition filed in state court on January 13, 2015, by its former Chairman and Senior Geologist, David J. Chernicky and entities he controls), CA -1.3%, AMD -1.3%, AMD -1.3%, FITB -1.3%, IBKR -1.2%, STNG -0.5%, .
Other news: ZFGN -7.1% (announces proposed public offering of of 2,840,909 shares of common stock), ARNA -6.6% (intends to offer and sell shares of its common stock), XON -4.3% ( announces proposed public offering of $150 million of its common stock ), MBLY -3.7% (has filed a registration statement for a secondary public offering by selling shareholders; size not disclosed),FANG -3.4% (launches $1.5 mln in common stock offering), KERX -3.3% (commenced a $100 mln underwritten public offering of shares of its common stock), PBYI -3.2% (announced it is commencing a public offering of 1 mln shares of its common stock; terms not disclosed), QCOM -3.1% (has been dropped from next Samsung (SSNLF) smartphone, according to reports), SYRG -3% (provided operations update and updated fiscal second quarter production guidance; co's second fiscal quarter production is running below expectations due to a delay in completions by other operators), ZINC -1.7% (announces it plans to offer 5 mln shares of its common stock), OWW -1.2% (following yesterday's intraday move higher on reports of potential sale)
Analyst comments: EGO -11.2% (downgraded to Neutral from Outperform at Credit Suisse), AN -3.5% (downgraded to Neutral from Buy at Goldman), WYNN -1.8% (downgraded to Neutral from Buy at Nomura), FMS -1.5% (downgraded to Neutral from Buy at UBS, downgraded to Equal Weight at Barclays), LVS -1.4% (downgraded to Neutral from Buy at Nomura), HEES -1.4% (downgraded to Neutral from Buy at UBS ), SRPT -1.1% (downgraded to Neutral from Outperform at Credit Suisse ), CL -0.9% (downgraded to Neutral from Buy at UBS), WMT -0.9% (downgraded to Equal-Weight from Overweight at Morgan Stanley), BRKS -0.8% (assumed with a Underperform at Credit Suisse), CHD -0.7% (downgraded to Neutral from Buy at UBS), VZ -0.5% (downgraded to Equal Weight from Overweight at Barclays)